Down 50% and Still Standing: 3 Growth Stocks Worth Your Attention Now

The article highlights three beaten-down consumer stocks—e.l.f. Beauty, DraftKings, and RH—as long-term opportunities, with each down around 50% from highs. E.l.f.'s acquisition of Rhode could expand distribution and growth, DraftKings may benefit if prediction-market sports contracts are restricted by law, and RH expects RH Estates to become its biggest growth and highest-margin business. Overall tone is constructive on company-specific growth drivers rather than reporting new hard financial results.

Analysis

The common thread here is that all three names are attempting to re-rate from narrative stocks to multi-engine platforms, but the market is pricing them as if each is still a single-product story. That creates a window where execution on distribution, app bundling, and premium mix can matter more than top-line growth alone; if management delivers, multiple expansion can outrun the underlying revenue cadence over the next 6-12 months.

ELF is the cleanest second-order beneficiary: Rhode turns the company from a mass-beauty disrupter into a bridge between prestige and mass, which should expand its TAM and improve retailer leverage. The real opportunity is not just incremental sales, but better shelf economics and a cheaper customer acquisition flywheel via creator-led demand; the risk is that Rhode's cachet weakens once scaled, so the next two quarters of channel acceptance and repeat purchase data matter more than headline launch buzz.

DKNG is less about betting volume and more about regulatory optionality. If prediction markets remain constrained, the stock has asymmetric upside because investors are currently discounting a prolonged margin drag while ignoring that a bundled super-app could actually raise ARPU and retention across states; if regulation breaks the other way, the multiple compression could continue for several quarters. RH is the highest-beta turnaround: if Estates creates a premium customization layer, it can lift average order values and showroom productivity, but the demand recovery timing is the key variable, not the concept itself.

The contrarian read is that consensus may be underestimating how much of the recent drawdowns were already enough to price in bad news. For ELF and DKNG, the key catalyst path is 1-2 quarters of cleaner execution rather than a macro rebound; for RH, the setup is more of a 12-24 month compounding story, and the stock likely remains range-bound until investors see evidence that the new format actually improves cash conversion rather than just adds complexity.

Key Decisions for Investors

• Long ELF on any post-launch weakness; 3-6 month horizon. Upside comes from Rhode scaling through existing distribution, with a better-than-2:1 reward/risk if sell-side numbers begin to reflect higher shelf productivity and repeat demand.
• Buy DKNG on pullbacks or via 6-12 month call spreads. The setup is asymmetric if prediction-market regulation tightens; downside is slower EBITDA expansion, but upside is multiple expansion as the market re-prices legal optionality and app bundling.
• Initiate a small starter long RH, but only if you can tolerate a 12-24 month hold. This is a premiumization/cash-flow story, not a quick recovery trade; use size conservatively because execution risk is high and macro demand remains soft.
• Pair trade: long ELF / short a weaker beauty peer with less distribution leverage. The thesis is that Rhode accelerates share gains and improves bargaining power with retailers faster than the market expects.
• For DKNG, consider a capped-risk bullish options structure ahead of regulatory headlines. The payoff is most attractive over the next 1-2 quarters if legal developments or product rollout improve investor confidence; hard stop if prediction-market adoption expands faster than expected.